Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Gladstone Lando Stock Better Than Industry Peers Price At 20.59 Up 2.13 20260402 Will Palladyne Pdynw Stock Go Higher Price At 0.08 Up 19.70 20260409 Is Wimi Wimi Stock Moving Higher Price At 1.91 Up 0.74 20260406 What Chart Pattern Is Silo Pharma Silo Stock Forming Price At 0.53 Up 49.02 20260407 KMT Kennametal exceeds profit expectations with 135 EPS beat but stock slides 1345 on revenue weakness FWDI shares climb 257 despite Forward Industries Q3 loss and 9 revenue decline SLM SLMBP Business Update Q4 2025 Better Than Expected Is Rallybio Corporation RLYB stock approaching a breakout zone Rallybio Corporation posts 139 EPS beat narrower than projected loss Cellyan HKPD quarterly earnings report shows no revenue EPS data available amid biotechnology sector headwinds ISBA Isabella reports far worse than expected Q4 2025 EPS sending shares down 63 percent today LTRX Lantronix Q1 2026 EPS tops forecasts by 42 percent year over year revenue falls 23 percent SandRidge Energy SD misses Q4 2025 EPS expectations sending shares 12 percent lower in todays session How Donaldson DCI is positioning for the next five years Grinds Lower 20260508 NEUP Neuphoria Therapeutics reports narrower than expected Q1 2026 loss shares climb 265 percent in todays trading HOVNP Hovnanian reports Q1 2026 profit against expected loss shares edge higher in todays trading Oil Rallies as USIran Deadlock Heightens Supply Concerns GXO Logistics GXO Stock Analysis 333 Loss Key Levels 20260515 Sony Increases PlayStation Plus Subscription Fees Citing Market Conditions KBR KBR Stock Today Unchanged at 3065 Key Levels 20260514 US Economic Growth Rebounds in Q1 2026 as AI Infrastructure and Consumer Spending Drive Expansion Telomir Pharmaceuticals TELO Q4 2025 Disappoints EPS 028 Below 007 Views Kadant KAI Stock Forecast Can 184 Upside Continue 20260521 Athene ATHS Flat at 2498 Consolidation Continues 20260521 Texas Instruments TXN Dips 2 as Semiconductor Sector Faces Headwinds VietnamThailand Relations Deepen as President To Lam Visits Bangkok Bond Market Signals Inflation Concerns as Kevin Warsh Assumes Fed Leadership SpaceX OpenAI and Anthropic IPOs Could Test the Limits of the AI Boom ADP Private Payrolls Beat Expectations in April Signaling Steady Labor Market and Dimming Rate Cut Hopes Vickers Insider Trading Report Highlights Buyers and Sellers for May 27 2026 Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues AQB Q3 2024 Earnings Narrowerthanexpected loss drives modest stock gain ANAB Q1 2026 Earnings Significant Earnings Miss Amid PreRevenue Stage IAC Q1 2026 Earnings WiderThanExpected Loss but Shares Rise KRNY Q1 2026 Earnings Slight EPS Miss Weighs on Shares After Mixed Quarter CN Energy Group Inc CNEY Faces Sharp Decline Testing Key Support Zone CAMP4 Therapeutics Surges 45 as Biotech Sentiment Improves CAMP Tests Key Resistance Allison Transmission Holdings ALSN Holds Steady Near Resistance A Technical and Fundamental Review Urban One Inc UONE Edges Higher as Media Stock Tests Key Resistance KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure Raja Venkatraman and MarketSmith Recommend Five Stocks as Indian Market Faces Consolidation STLD Q1 2026 Earnings EPS Falls Slightly Short of Estimates Amid Steady Operations Foxconn to Begin Shipping NextGeneration Optical Technology for AI Data Centers Corebridge CRBG Stock Static Quote Marginal Gain 20260420 Atlanticus ATLCZ Stock Should You Buy At Highs 20260420 RILYG BRC Group posts negative Q1 2024 EPS as its stock gains 111 percent on positive investor sentiment NIO Inc NIO Stock Price Action Trade Investors Pile In 20260422 Tactile TCMD Stock Is It Trading Cheap Q4 2025 EPS Exceeds Expectations SCWO 374Water shares rise 255 percent despite wider than expected Q3 2025 loss and sharp year over year revenue drop Bristol Myers Squibb BMY Partners With Pfizer to List Blockbuster Anticoagulant Eliquis on Mark Cuban Cost Plus Platform at 345 Monthly